NYSE:ALife Sciences
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News
In February 2026, Agilent Technologies announced that it will pay a US$0.255 quarterly dividend per share on April 22, 2026, to shareholders of record as of March 31, 2026, while also receiving U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx companion diagnostic to guide first-line use of Keytruda in several hard-to-treat cancers including epithelial ovarian carcinoma.
This latest FDA approval broadens Agilent’s role in precision oncology diagnostics, potentially deepening its integration...